Home > Qtrly Results > SUN PHARMACEUTICAL INDUSTRIES

SUN PHARMACEUTICAL INDUSTRIES
Quarterly Results Analysis [Sep2024]

SUN PHARMACEUTICAL INDUSTRIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for SUN PHARMACEUTICAL INDUSTRIES
Please provide your vote to see the results

SUN PHARMACEUTICAL INDUSTRIES Quarterly Results

Consolidated Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Mar2023
Audited
Dec2022
UnAudited
Revenues ₹13,291 Cr ₹12,653 Cr ₹11,983 Cr ₹12,381 Cr ₹12,192 Cr ₹11,941 Cr ₹10,931 Cr ₹11,241 Cr
Expenses ₹9,481 Cr ₹9,045 Cr ₹8,948 Cr ₹9,028 Cr ₹9,013 Cr ₹8,611 Cr ₹8,129 Cr ₹8,237 Cr
Operating Income ₹3,811 Cr ₹3,608 Cr ₹3,035 Cr ₹3,352 Cr ₹3,179 Cr ₹3,330 Cr ₹2,802 Cr ₹3,004 Cr
Other Income ₹482 Cr ₹533 Cr ₹606 Cr ₹375 Cr ₹294 Cr ₹206 Cr ₹373 Cr ₹174 Cr
Interest ₹69 Cr ₹62 Cr ₹74 Cr ₹35 Cr ₹49 Cr ₹81 Cr ₹93 Cr ₹46 Cr
Depreciation ₹626 Cr ₹655 Cr ₹650 Cr ₹622 Cr ₹633 Cr ₹651 Cr ₹672 Cr ₹660 Cr
Profit Before Tax ₹3,598 Cr ₹3,424 Cr ₹2,816 Cr ₹3,000 Cr ₹2,791 Cr ₹2,481 Cr ₹2,240 Cr ₹2,471 Cr
Profit After Tax ₹3,031 Cr ₹2,871 Cr ₹2,667 Cr ₹2,568 Cr ₹2,401 Cr ₹2,013 Cr ₹2,017 Cr ₹2,188 Cr
EPS ₹12.67 ₹11.82 ₹11.06 ₹10.52 ₹9.90 ₹8.43 ₹8.27 ₹9.03
Industry Peers & Returns1W1M1Y
SUN PHARMACEUTICAL INDUSTRIES -0.2% 0.1% 47%
CIPLA -2% -7.7% 23.2%
DR REDDYS LABORATORIES 2.6% -1.5% 7.9%
ZYDUS LIFESCIENCES 2.1% 0.6% 54.5%
DIVIS LABORATORIES -1.9% 5.5% 60.6%
MANKIND PHARMA -1.2% -4.8% 36.6%
TORRENT PHARMACEUTICALS -0.2% 4.6% 57.8%
LUPIN 3.1% -2.2% 68.7%
AUROBINDO PHARMA -0.8% -10.8% 19.3%

SUN PHARMACEUTICAL INDUSTRIES Quarterly Revenues

Revenues
Q-o-Q

5.05 %

Y-o-Y

9.01 %

Quarters Revenues % Change
Sep2024 ₹13,291 Cr
5.05
Jun2024 ₹12,653 Cr
5.59
Mar2024 ₹11,983 Cr
-3.21
Dec2023 ₹12,381 Cr
1.54
Sep2023 ₹12,192 Cr
2.11
Jun2023 ₹11,941 Cr
9.24
Mar2023 ₹10,931 Cr
-2.76
Dec2022 ₹11,241 Cr -

SUN PHARMACEUTICAL INDUSTRIES Quarterly Operating Profit

Operating Profit
Q-o-Q

5.63 %

Y-o-Y

19.86 %

Quarters Operating Profit % Change
Sep2024 ₹3,811 Cr
5.63
Jun2024 ₹3,608 Cr
18.86
Mar2024 ₹3,035 Cr
-9.46
Dec2023 ₹3,352 Cr
5.44
Sep2023 ₹3,179 Cr
-4.52
Jun2023 ₹3,330 Cr
18.83
Mar2023 ₹2,802 Cr
-6.71
Dec2022 ₹3,004 Cr -
Operating Margins
Q-o-Q

0.56 %

Y-o-Y

9.93 %

Quarters Operating Margin% % Change
Sep2024 28.67%
0.56
Jun2024 28.51%
12.55
Mar2024 25.33%
-6.46
Dec2023 27.08%
3.83
Sep2023 26.08%
-6.49
Jun2023 27.89%
8.78
Mar2023 25.64%
-4.04
Dec2022 26.72% -

SUN PHARMACEUTICAL INDUSTRIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

5.55 %

Y-o-Y

26.24 %

Quarters Profit After Tax % Change
Sep2024 ₹3,031 Cr
5.55
Jun2024 ₹2,871 Cr
7.67
Mar2024 ₹2,667 Cr
3.84
Dec2023 ₹2,568 Cr
6.97
Sep2023 ₹2,401 Cr
19.26
Jun2023 ₹2,013 Cr
-0.19
Mar2023 ₹2,017 Cr
-7.83
Dec2022 ₹2,188 Cr -
PAT Margins
Q-o-Q

0.48 %

Y-o-Y

15.79 %

Quarters PAT Margin(%) % Change
Sep2024 22.8 %
0.48
Jun2024 22.69 %
1.98
Mar2024 22.25 %
7.28
Dec2023 20.74 %
5.33
Sep2023 19.69 %
16.79
Jun2023 16.86 %
-8.62
Mar2023 18.45 %
-5.19
Dec2022 19.46 % -

SUN PHARMACEUTICAL INDUSTRIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

7.19 %

Y-o-Y

27.98 %

Quarters EPS % Change
Sep2024 ₹12.67
7.19
Jun2024 ₹11.82
6.87
Mar2024 ₹11.06
5.13
Dec2023 ₹10.52
6.26
Sep2023 ₹9.9
17.44
Jun2023 ₹8.43
1.93
Mar2023 ₹8.27
-8.42
Dec2022 ₹9.03 -

You may also like the below Video Courses